Keiser MS - Search Results

1

Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.

Keiser MS, Kordower JH, Gonzalez-Alegre P, Davidson BL. Keiser MS, et al. Brain. 2015 Dec;138(Pt 12):3555-66. doi: 10.1093/brain/awv292. Epub 2015 Oct 21. Brain. 2015. PMID: 26490326 Free PMC article.

2

Altered Purkinje cell miRNA expression and SCA1 pathogenesis.

Rodriguez-Lebron E, Liu G, Keiser M, Behlke MA, Davidson BL. Rodriguez-Lebron E, et al. Neurobiol Dis. 2013 Jun;54:456-63. doi: 10.1016/j.nbd.2013.01.019. Epub 2013 Jan 30. Neurobiol Dis. 2013. PMID: 23376683 Free PMC article.

3

RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1.

Keiser MS, Geoghegan JC, Boudreau RL, Lennox KA, Davidson BL. Keiser MS, et al. Neurobiol Dis. 2013 Aug;56:6-13. doi: 10.1016/j.nbd.2013.04.003. Epub 2013 Apr 10. Neurobiol Dis. 2013. PMID: 23583610 Free PMC article.

4

Recent advances in RNA interference therapeutics for CNS diseases.

Ramachandran PS, Keiser MS, Davidson BL. Ramachandran PS, et al. Among authors: keiser ms. Neurotherapeutics. 2013 Jul;10(3):473-85. doi: 10.1007/s13311-013-0183-8. Neurotherapeutics. 2013. PMID: 23589092 Free PMC article. Review.

5

Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy.

Keiser MS, Boudreau RL, Davidson BL. Keiser MS, et al. Mol Ther. 2014 Mar;22(3):588-595. doi: 10.1038/mt.2013.279. Epub 2013 Dec 12. Mol Ther. 2014. PMID: 24419082 Free PMC article.

6

Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia.

Keiser MS, Kordasiewicz HB, McBride JL. Keiser MS, et al. Hum Mol Genet. 2016 Apr 15;25(R1):R53-64. doi: 10.1093/hmg/ddv442. Epub 2015 Oct 26. Hum Mol Genet. 2016. PMID: 26503961 Free PMC article. Review.

7

RNAi prevents and reverses phenotypes induced by mutant human ataxin-1.

Keiser MS, Monteys AM, Corbau R, Gonzalez-Alegre P, Davidson BL. Keiser MS, et al. Ann Neurol. 2016 Nov;80(5):754-765. doi: 10.1002/ana.24789. Epub 2016 Nov 2. Ann Neurol. 2016. PMID: 27686464 Free PMC article.

8

CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo.

Monteys AM, Ebanks SA, Keiser MS, Davidson BL. Monteys AM, et al. Among authors: keiser ms. Mol Ther. 2017 Jan 4;25(1):12-23. doi: 10.1016/j.ymthe.2016.11.010. Epub 2017 Jan 4. Mol Ther. 2017. PMID: 28129107 Free PMC article.

9

RNA Interference of Human α-Synuclein in Mouse.

Kim YC, Miller A, Lins LC, Han SW, Keiser MS, Boudreau RL, Davidson BL, Narayanan NS. Kim YC, et al. Among authors: keiser ms. Front Neurol. 2017 Jan 31;8:13. doi: 10.3389/fneur.2017.00013. eCollection 2017. Front Neurol. 2017. PMID: 28197125 Free PMC article.

10

The long non-coding RNA NEAT1 is elevated in polyglutamine repeat expansion diseases and protects from disease gene-dependent toxicities.

Cheng C, Spengler RM, Keiser MS, Monteys AM, Rieders JM, Ramachandran S, Davidson BL. Cheng C, et al. Among authors: keiser ms. Hum Mol Genet. 2018 Dec 15;27(24):4303-4314. doi: 10.1093/hmg/ddy331. Hum Mol Genet. 2018. PMID: 30239724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page